Ciprofol Versus Propofol for Anesthesia Induction in Cardiac Surgery: A Randomized Double-blind Controlled Clinical Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
Ciprofol, a novel intravenous general anesthetic with a chemical structure akin to propofol, boasts significantly enhanced potency. It offers a rapid onset, reduced incidence of injection pain, and minor impact on the cardiovascular system. However, clinical research regarding ciprofol's use for anesthesia induction in cardiac surgery remains limited.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 10, 2024
CompletedStudy Start
First participant enrolled
March 11, 2024
CompletedFirst Posted
Study publicly available on registry
March 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2024
CompletedMarch 15, 2024
March 1, 2024
2 months
March 10, 2024
March 10, 2024
Conditions
Outcome Measures
Primary Outcomes (8)
Mean arterial pressure
an average blood pressure in an individual during a single cardiac cycle
1 second before induction of anesthesia (T1)
Mean arterial pressure
an average blood pressure in an individual during a single cardiac cycle
1 second before tracheal intubation (T2)
Mean arterial pressure
an average blood pressure in an individual during a single cardiac cycle
1 minute after tracheal intubation (T3)
Mean arterial pressure
an average blood pressure in an individual during a single cardiac cycle
5 minutes after tracheal intubation (T4)
Heart beats
the number of times each minute that heart beats
1 second before induction of anesthesia (T1)
Heart beats
the number of times each minute that heart beats
1 second before tracheal intubation (T2)
Heart beats
the number of times each minute that heart beats
1 minute after tracheal intubation (T3)
Heart beats
the number of times each minute that heart beats
5 minutes after tracheal intubation (T4)
Secondary Outcomes (3)
Oxygenation index
1 second before induction of anesthesia (T1)
Oxygenation index
10 minutes after tracheal intubation (T5)
Injection pain
During procedure (When injecting the drug, ask the subject if the injection site is painful)
Study Arms (2)
Experimental: ciprofol
EXPERIMENTALPlacebo Comparator: propofol
PLACEBO COMPARATORInterventions
Patients in ciprofol group 0.3 mg/kg ciprofol for induction of anesthesia
Eligibility Criteria
You may qualify if:
- Elective surgery patients
- Aged 55 to 75
- New York Heart Association class II or III cardiac functions
- Median sternotomy approach for coronary artery bypass grafting or heart valve replacement procedures
You may not qualify if:
- With a history of benzodiazepine allergy
- Significant liver or kidney insufficiency
- Coagulation dysfunction
- Neurological or psychiatric disorders
- Undergone major surgery within the past three months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Le Yulead
Study Sites (1)
Shanghai East Hospital of Tongji University
Shanghai, Shanghai Municipality, 200120, China
Related Publications (1)
Yu L, Liu X, Zhao X, Shan X, Bischof E, Lu HH. Ciprofol versus propofol for anesthesia induction in cardiac surgery: a randomized double-blind controlled clinical trial. BMC Anesthesiol. 2024 Nov 12;24(1):412. doi: 10.1186/s12871-024-02795-0.
PMID: 39533186DERIVED
MeSH Terms
Interventions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinicians
Study Record Dates
First Submitted
March 10, 2024
First Posted
March 15, 2024
Study Start
March 11, 2024
Primary Completion
May 1, 2024
Study Completion
May 10, 2024
Last Updated
March 15, 2024
Record last verified: 2024-03